Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 4
2007 8
2008 8
2009 1
2010 2
2011 1
2012 2
2013 2
2014 2
2015 4
2016 4
2017 1
2018 4
2019 9
2020 6
2021 10
2022 10
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Eight-Year Outcomes of Bilateral Lateral Rectus Recessions versus Unilateral Recession-Resection in Childhood Basic-Type Intermittent Exotropia.
Donahue SP, Chandler DL, Wu R, Marsh JD, Law C, Areaux RG Jr, Ghasia FF, Li Z, Kraker RT, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Donahue SP, et al. Ophthalmology. 2024 Jan;131(1):98-106. doi: 10.1016/j.ophtha.2023.09.004. Epub 2023 Sep 9. Ophthalmology. 2024. PMID: 37696452 Clinical Trial.
A Pilot Randomized Clinical Trial of Base-in Relieving Prism Spectacle Treatment of Intermittent Exotropia.
Summers AI, Morrison DG, Chandler DL, Henderson RJ, Chen AM, Leske DA, Walker KR, Li Z, Melia BM, Bitner DP, Kurup SP, Allen M, Phillips PH, Nash DL, Grigorian AP, Kraus CL, Miller AM, Titelbaum JR, Kraker RT, Holmes JM, Cotter SA; Pediatric Eye Disease Investigator Group. Summers AI, et al. Optom Vis Sci. 2023 Jul 1;100(7):432-443. doi: 10.1097/OPX.0000000000002039. Epub 2023 Jul 1. Optom Vis Sci. 2023. PMID: 37399233 Clinical Trial.
Improved control of intermittent exotropia with part-time patching.
Hatt SR, Kraker RT, Leske DA, Chandler DL, Fallaha N, Mohney BG, Ticho BH, Li Z, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Hatt SR, et al. J AAPOS. 2023 Jun;27(3):160-163. doi: 10.1016/j.jaapos.2023.02.011. Epub 2023 May 13. J AAPOS. 2023. PMID: 37187406 Clinical Trial.
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity.
Wallace DK, Hercinovic A, Freedman SF, Crouch ER, Bhatt AR, Hartnett ME, Yang MB, Rogers DL, Hutchinson AK, Good WV, Repka MX, Li Z, Beck RW, Kraker RT, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Wallace DK, et al. J AAPOS. 2023 Feb;27(1):10.e1-10.e8. doi: 10.1016/j.jaapos.2022.11.020. Epub 2023 Jan 19. J AAPOS. 2023. PMID: 36681111 Free PMC article.
Relationships among Clinical Factors and Patient-reported Outcome Measures in Adults with Convergence Insufficiency.
Lorenzana IJ, Leske DA, Hatt SR, Dean TW, Jenewein EC, Dagi LR, Beal CJ, Pang Y, Retnasothie DV, Esposito CA, Erzurum SA, Aldrich AE, Crouch ER, Li Z, Kraker RT, Holmes JM, Cotter SA; Pediatric Eye Disease Investigator Group; Pediatric Eye Disease Investigator Group. Lorenzana IJ, et al. Optom Vis Sci. 2022 Sep 1;99(9):692-701. doi: 10.1097/OPX.0000000000001929. Epub 2022 Aug 2. Optom Vis Sci. 2022. PMID: 35914096 Free PMC article.
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
Freedman SF, Hercinovic A, Wallace DK, Kraker RT, Li Z, Bhatt AR, Boente CS, Crouch ER, Hubbard GB, Rogers DL, VanderVeen D, Yang MB, Cheung NL, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Freedman SF, et al. Ophthalmology. 2022 Oct;129(10):1120-1128. doi: 10.1016/j.ophtha.2022.05.019. Epub 2022 Jun 1. Ophthalmology. 2022. PMID: 35660415 Free PMC article.
74 results